HRMY (Harmony Biosciences Holdings, Inc.) Stock Financials & Earnings

HRMYHarmony Biosciences Holdings, Inc.

Mkt Cap$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$868M

Net Income (TTM)$159M

EPS (TTM)$2.71

Free Cash Flow (TTM)$348M

Gross Margin77.2%

Op. Margin24.0%

Net Margin18.3%

FCF Margin40.1%

P/S Ratio (TTM)1.9x

P/E Ratio (TTM)10.4x

YoY Rev Growth+21.5%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$119M	$98M	$40M
Q2 23	$134M	$109M	$47M
Q3 23	$160M	$128M	$65M
Q4 23	$168M	$125M	$40M
Q1 24	$155M	$127M	$52M
Q2 24	$173M	$141M	$21M
Q3 24	$186M	$143M	$62M
Q4 24	$201M	$147M	$56M
Q1 25	$185M	$153M	$56M
Q2 25	$200M	$162M	$48M
Q3 25	$239M	$180M	$65M
Q4 25	$244M	$175M	$39M

Revenue Breakdown

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 23	$13M	$22M	$23M
Q2 23	$15M	$23M	$25M
Q3 23	$17M	$23M	$23M
Q4 23	$30M	$28M	$27M
Q1 24	$22M	$26M	$27M
Q2 24	$64M	$27M	$29M
Q3 24	$25M	$29M	$28M
Q4 24	$35M	$29M	$28M
Q1 25	$35M	$31M	$31M
Q2 25	$50M	$34M	$30M
Q3 25	$55M	$30M	$30M
Q4 25	$50M	$58M	$29M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$288M	$56M	$344M
Q2 23	$317M	$54M	$371M
Q3 23	$325M	$46M	$371M
Q4 23	$312M	$42M	$353M
Q1 24	$333M	$39M	$372M
Q2 24	$317M	$30M	$347M
Q3 24	$387M	$23M	$410M
Q4 24	$453M	$14M	$467M
Q1 25	$489M	$18M	$507M
Q2 25	$546M	$19M	$565M
Q3 25	$647M	$26M	$673M
Q4 25	$753M	$23M	$775M

Shares Outstanding

Revenue Per Employee

Revenue / Employee